Advertisement
Hani Najm, MD, MSc, FACC, takes leadership role in leading cardiovascular society
An expert’s take on four trials in three minutes
But no difference in survival if there is no dysfunction
Elevated risk mitigated by proper techniques in appropriately sized vessels
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Trial stopped early after evacetrapib fails to budge event rate
Allergic reactions doom factor IXa inhibitor and antidote
Advertisement
Advertisement